Observation on the Effect of Non-Invasive Ventilator Combined with Conventional Therapy in the Treatment of Chronic Obstructive Pulmonary Disease Complicated with Respiratory Failure

Objective:To explore the clinical effect of a non-invasive ventilator combined with conventional therapy in the treatment of patients with chronic obstructive pulmonary disease(COPD)combined with respiratory failure.Methods:68 patients with COPD combined with respiratory failure treated in our hospital from September 2021 to October 2023 were selected as the research subjects.Using the random number table method,they were divided into a control group and an experimental group of 34 cases each.The control group received conventional symptomatic treatment,and the experimental group received non-invasive ventilator treatment based on the control group.The clinical effects,blood gas indicators(partial pressure of carbon dioxide(PaCO_(2)),partial pressure of oxygen(PaO_(2)),arterial oxygen saturation(SaO_(2))),lung function(forced expiratory volume in 1 second(FEV1),forced vital capacity(FVC),6 min walking distance),complications,and inflammatory factor levels(c-reactive protein(CRP),interleukin-6(IL-6),neutrophil-to-lymphocyte ratio(NLR))of the two groups of patients were observed.Results:(1)The clinical efficacy of the patients in the experimental group(33/97.06%)was more significant as compared with the control group(25/73.53%)(P<0.05);(2)After treatment,the clinical efficacy of the two groups of patients in terms of FEV1,FEV1/FVC,6-minute walking distance,PaO_(2)and SaO_(2)all increased in the experimental group as compared to that of the control group(P<0.05);(3)After treatment,the PaCO_(2),CRP,IL-6,and NLR of the two groups of patients decreased,and the decrease in the experimental group was higher than that of the control group(P<0.05);(4)The patients’complication rate in the experimental group(2/5.88%)was lower as compared to that of the control group(9/26.46%)(P<0.05).Conclusion:Non-invasive ventilators combined with conventional therapy achieved good clinical results in treating patients with COPD and respiratory failure.

Clinical Study on Respiratory Medicine Treatment of Chronic Obstructive Pulmonary Disease Combined with Respiratory Failure

Objective:To explore the respiratory medicine treatment methods for treating chronic obstructive pulmonary disease(COPD)combined with respiratory failure.Methods:70 cases of COPD patients with combined respiratory failure admitted to our hospital from January 2021 to January 2023 were selected as the study subjects,and randomly divided into the control group and the experimental group,each with 35 cases.The control group received only conventional treatment,and the experimental group received non-invasive positive pressure ventilation,and the treatment effects and changes in the levels of IL-18,hs-CRP,and CES2 inflammatory factors were observed and evaluated in the two groups.Results:There was no significant difference between the general data of the two groups(P>0.05);after treatment,the total effective rate of clinical efficacy of the observation group(91.43%)was significantly higher than that of the control group(71.43%),and the difference showed a significant correlation(P<0.05);after treatment,the level of inflammatory factor of the observation group was significantly reduced compared with that of the control group,and the difference showed a highly significant correlation(P<0.001).Conclusion:The non-invasive positive pressure ventilation treatment program significantly improves the therapeutic effect,effectively controls the level of inflammatory factors,and improves the health status of patients when dealing with patients with chronic obstructive pulmonary disease accompanied by respiratory failure,showing a good clinical application prospect.

Evaluation of the Effect of Comfort Nursing on Patients with Chronic Obstructive Pulmonary Disease Complicated with Respiratory Failure

Objective:To explore and analyze the effect of comfort nursing in patients with chronic obstructive pulmonary disease(COPD)complicated with respiratory failure.Methods:60 patients with COPD and respiratory failure who were admitted to the Department of Respiratory Medicine of our hospital from May 2020 to May 2023 were selected as subjects of this study,and they were divided into comfort group and reference group by odd and even number draw method,with 30 cases in each group.The comfort group received comfort nursing,and the reference group received general nursing.The lung function performance and living conditions were compared between the groups.Results:Before the intervention,there was no statistically significant difference(P>0.05)in terms of lung functions such as forced expiratory volume in the first second(FEV1),forced vital capacity(FVC),and the ratio FEV1/FVC between the groups;after the intervention,the lung functions of the comfort group were significantly better than those in the reference group(P<0.05).Before the intervention,there was no statistically significant difference(P>0.05)between the groups in terms of mental state,physical function,social situation,and spiritual aspects;after the intervention,the mental state,physical function,social situation,and spiritual aspects of the comfort group were significantly better than those of the reference group(P<0.05).Conclusion:Comfort nursing care for COPD patients with respiratory failure can improve their lung function and quality of life,and achieve ideal nursing effects.

Clinical evaluation of ventilation mode on acute exacerbation of chronic obstructive pulmonary disease with respiratory failure

BACKGROUND At present,understanding of the most effective ventilation methods for treating chronic obstructive pulmonary disease(COPD)patients experiencing acute worsening symptoms and respiratory failure remains relatively limited.This report analyzed the efficiency and side effects of various ventilation techniques used for individuals experiencing an acute COPD exacerbation.AIM To determine whether pressure-controlled ventilation(PCV)can lower peak airway pressures(PAPs)and reduce the incidence of barotrauma compared to volume-controlled ventilation(VCV),without compromising clinical outcomes and oxygenation parameters.METHODS We have evaluated 600 patients who were hospitalized due to a severe COPD exacerbation,with 400 receiving mechanical ventilation for the respiratory failure.The participants were divided into two different groups,who were administered either VCV or PCV,along with appropriate management.We thereafter observed patients'attributes,clinical factors,and laboratory,radiographic,and arterial blood gas evaluations at the start and during their stay in the intensive care unit(ICU).We have also employed appropriate statistical methods for the data analysis.RESULTS Both the VCV and PCV groups experienced significant enhancements in the respiratory rate,tidal volume,and arterial blood gas values during their time in the ICU.However,no significant distinctions were detected between the groups in terms of oxygenation indices(partial pressures of oxygen/raction of inspired oxygen ratio)and partial pressures of carbon dioxide improvements.There was no considerable disparity observed between the VCV and PCV groups in the hospital mortality(32%vs 28%,P=0.53),the number of days of ICU stay[median interquartile range(IQR):9(6-14)d vs 8(5-13)d,P=0.41],or the duration of the mechanical ventilation[median(IQR):6(4-10)d vs 5(3-9)d,P=0.47].The PCV group displayed lower PAPs compared to the VCV group(P<0.05)from the beginning of mechanical ventilation until extubation or ICU departure.The occurrence of barotrauma was considerably lower in the PCV group in comparison to the VCV group(6%vs 16%,P=0.03).CONCLUSION Both VCV and PCV were found to be effective in treating patients with acute COPD exacerbation.However,PCV was associated with lower PAPs and a significant decrease in barotrauma,thus indicating that it might be a safer ventilation method for this group of patients.However,further large-scale study is necessary to confirm these findings and to identify the best ventilation approach for patients experiencing an acute COPD exacerbation.

Role of diaphragmatic ultrasound in patients with acute exacerbation of chronic obstructive pulmonary disease

Assessing diaphragm function status is vital for diagnosing and treating acute exacerbation of chronic obstructive pulmonary disease(AECOPD).Diaphrag-matic ultrasound has become increasingly important due to its non-invasive nature,absence of radiation exposure,widespread availability,prompt results,high accuracy,and repeatability at the bedside.The diaphragm is a crucial respiratory muscle.Decline or dysfunction of the diaphragm can lead to dyspnea and even respiratory failure in AECOPD patients.In this editorial,we comment on an article,retrospectively analyzed ninety-four acute exacerbations of chronic obstructive pulmonary disease patients who received mechanical ventilation from January 2022 to December 2023.The study found that the diaphragm thickening fraction,an index from diaphragm ultrasound,can better predict the outcome of non-invasive ventilation in patients with AECOPD.The value of non-invasive ventilation in treating respiratory failure caused by AECOPD has been widely acknowledged.Diaphragmatic dysfunction diagnosed with ultrasound is asso-ciated with prolonged mechanical ventilation and weaning times and higher mortality.

Effects of low molecular weight heparin on the function of blood coagulation and serum levels of TNF-α, CK-MB, CRP of patients with acute exacerbations of chronic obstructive pulmonary diseases and respiratory failur

Objective:To study the effects of low molecular weight heparin on the function of blood coagulation and serum levels of tumor necrosis factor-α(TNF-α), creatine kinase isoenzyme (CK-MB), C-reactive protein (CRP) of patients with acute exacerbations of chronic obstructive pulmonary diseases and respiratory failure.Methods:A total of 80 patients with acute exacerbations of chronic obstructive pulmonary diseases and respiratory failure in our hospital from June 2014 to October 2016 were enrolled in this study. The subjects were divided into the control group (n=40) and the treatment group (n=40) randomly. The control group were treated with conventional treatment, the treatment group were treated with the conventional treatment combined with low molecular weight heparin. The two groups were treated for 7 d. The D-dimer (D-D), fibrinogen (FBG), pro thrombin time (PT), thrombin time (TT), TNF-α, CK-MB and CRP of the two groups before and after treatment were compared.Results:There were no significantly differences of the blood levels of D-D, FBG, PT and TT of the two groups before treatment. After treatment, the blood levels of D-D and FBG of the two groups were significantly lower than before treatment, and that of the treatment group were significantly lower than the control group, the PT and TT of the two groups were significantly higher than before treatment, and that of the treatment group were significantly higher than the control group. There were no significantly differences of the serum levels of the TNF-α, CK-MB and CRP of the two groups before treatment. After treatment, the serum levels of the TNF-α, CK-MB and CRP of the two groups were significantly lower than before treatment, and that of the treatment group were significantly lower than the control group.Conclusion:Low molecular weight heparin can significantly reduce the inflammatory factors of the patients with acute exacerbations of chronic obstructive pulmonary diseases and respiratory failure, can alleviath the patients conditions and reduce the myocardial damage.

Application of fiberoptic bronchscopy in patients with acute exacerbations of chronic obstructive pulmonary disease during sequential weaning of invasive-noninvasive mechanical ventilation

BACKGROUND:Early withdrawal of invasive mechanical ventilation(IMV) followed by noninvasive MV(NIMV) is a new strategy for changing modes of treatment in patients with acute exacerbations of chronic obstructive pulmonary disease(AECOPD) with acute respiratory failure(ARF).Using pulmonary infection control window(PIC window) as the switch point for transferring from invasive to noninvasive MV,the time for early extubation can be more accurately judged,and therapy efficacy can be improved.This study aimed to prospectively investigate the clinical effectiveness of fiberoptic bronchscopy(FOB) in patients with AECOPD during sequential weaning of invasive-noninvasive MV.METHODS:Since July 2006 to January 2011,106 AECOPD patients with ARF were treated with comprehensive medication and IMV after hospitalization.Patients were randomly divided into two groups according to whether fiberoptic bronchoscope is used(group A,n=54) or not(group B,n=52) during sequential weaning from invasive to noninvasive MV.In group A,for sputum suction and bronchoalveolar lavage(BAL),a fiberoptic bronchoscope was put into the airway from the outside of an endotracheal tube,which was accompanied with uninterrupted use of a ventilator.After achieving PIC window,patients of both groups changed to NIMV mode,and weaned from ventilation.The following listed indices were used to compare between the groups after treatment:1) the occurrence time of PIC,the duration of MV,the length of ICU stay,the success rate of weaning from MV for the first time,the rate of reventilatJon and the occurrence rate of ventilator-associated pneumonia(VAP);2) the convenience and safety of FOB manipulation.The results were compared using Student's f test and the Chi-square test.RESULTS:The occurrence time of PIC was(5.01 ±1.49) d,(5.87±1.87) d in groups A and B,respectively(P<0.05);the duration of MV was(6.98±1.84) d,(8.69±2.41) d in groups A and B,respectively(P<0.01);the length of ICU stay was(9.25±1.84) d,(11.10±2.63) d in groups A and B,respectively(P<0.01);the success rate of weaning for the first time was 96.30%,76.92%in groups A and B,respectively(P<0.01);the rate of reventilation was 5.56%,19.23%in groups A and B,respectively(P<0.05);and the occurrence rate of VAP was 3.70%,23.07%in groups A and B,respectively(P<0.01).Moreover,it was easy and safe to manipulate FOB,and no side effect was observed.CONCLUSIONS:The application of FOB in patients with AECOPD during sequential weaning of invasive-noninvasive MV is effective in ICU.It can decrease the duration of MV and the length of ICU stay,increase the success rate from weaning MV for the first time,reduce the rate of reventilation and the occurrence rate of VAP.In addition,such a method is convenient and safe in patients of this kind.

Uniphyline-Induced Hypophosphatemia: A Rare Etiology of Severe Respiratory Failure

Hypophosphataemia is defined as low level of phosphate in the blood (normal range 0.8 - 1.4 mmol/l), which can be drug-induced such as uniphyline. We present a case of elderly female patient with known chronic obstructive pulmonary disease, admitted with acute respiratory failure and low serum phosphate level, her clinical signs and serum phosphate level did not improve with conventional therapy and intravenous phosphate replacement, until her recently commenced uniphyline was discontinued. This highlights the importance of awareness amongst the clinicians about this rare but potential side effect of uniphyline. We suggest monitoring phosphate levels in patients admitted with acute respiratory failure especially those on extended bronchodilator therapy.

Effect of adjuvant noninvasive positive pressure ventilation on blood gas parameters, cardiac function and inflammatory state in patients with COPD and type II respiratory failure

Objective:T o analyze the effect of adjuvant noninvasive positive pressure ventilation on blood gas parameters, cardiac function and inflammatory state in patients with chronic obstructive pulmonary disease (COPD) and type II respiratory failure. Methods:90 patients with COPD and type II respiratory failure were randomly divided into observation group and control group (n=45). Control group received conventional therapy, observation group received conventional therapy+adjuvant noninvasive positive pressure ventilation, and differences in blood gas parameters, cardiac function, inflammatory state, etc., were compared between two groups of patients 2 weeks after treatment. Results:Arterial blood gas parameters pH and alveolar-arterial partial pressure of oxygen [P(A-a)O2] levels of observation group were higher than those of control group while, potassium ion (K+), chloride ion (Cl-) and carbon dioxide combining power (CO2CP) levels were lower than those of control group 2 weeks after treatment;echocardiography parameters Doppler-derived tricuspid lateral annular systolic velocity (DTIS) and pulmonary arterial velocity (PAV) levels were lower than those of control group (P<0.05) while pulmonary artery accelerating time (PAACT), left ventricular end-diastolic dimension (LVDd) and right atrioventricular tricuspid annular plane systolic excursion (TAPSE) levels were higher than those of control group (P<0.05);serum cardiac function indexes adiponectin (APN), Copeptin, N-terminal pro-B-type natriuretic peptide (NT-proBNP), cystatin C (CysC), growth differentiation factor-15 (GDF-15) and heart type fatty acid binding protein (H-FABP) content were lower than those of control group (P<0.05);serum inflammatory factors hypersensitive C-reactive protein (hs-CRP), tumor necrosis factor-α(TNF-α), interleukin-1β(IL-1β), IL-8, IL-10, and transforming growth factor-β1 (TGF-β1) content were lower than those of control group (P<0.05). Conclusions:Adjuvant noninvasive positive pressure ventilation can optimize the blood gas parameters, cardiac function and inflammatory state in patients with COPD and type II respiratory failure, and it is of positive significance in improving the overall treatment outcome.

Construction of Risk Prediction Model of Cardiac Arrest in Patients with Chronic Obstructive Pulmonary Disease Complicated with Respiratory Failure

Objective:To construct a risk prediction model for in-hospital cardiac arrest(IHCA)in patients with chronic obstructive pulmonary disease(COPD)complicated with respiratory failure.Methods:The clinical data of 550 patients with COPD complicated with respiratory failure in our hospital from January 2016 to June 2022 were retrospectively analyzed.According to the occurrence of IHCA,they were divided into the IHCA group and non-IHCA group.The general data and clinical indicators of the two groups were compared,and logistic regression analysis was performed,R software was used to establish the risk prediction model(nomogram model)for predicting the occurrence of IHCA in patients with COPD complicated with respiratory failure.The risk prediction model(line graph model)for patients with IHCA was validated by the Bootstrap method,and the predictive value was analyzed by applying the receiver operating characteristic(ROC)curve.Results:Among 550 COPD patients complicated with respiratory failure,95 cases(17.27%)had IHCA.There were significant differences in age,old myocardial infarction,heart failure,moderate and severe chronic kidney disease,assisted breathing mode,state of consciousness,body temperature,heart rate,respiratory rate,systolic blood pressure,lactic acid,Sa O,Pa CO,serum creatinine,albumin,and prealbumin between the non-IHCA group and IHCA group(P<0.05).Logistic regression analysis showed that age,heart failure,heart rate,respiratory rate,systolic blood pressure,unclear state of consciousness,serum creatinine and prealbumin were independent influencing factors of IHCA in COPD patients complicated with respiratory failure(P<0.05).According to the results of binary logistic regression analysis,a nomogram model for predicting the incidence of IHCA in COPD patients complicated with respiratory failure was constructed.The fitting degree of the model was determined by the H-L test.The calibration curve showed that the incidence of IHCA in COPD patients complicated with respiratory failure predicted by nomogram was in good agreement with the actual incidence of IHCA in patients with COPD complicated with respiratory failure(χ~2=2.017,P=0.334).The ROC curve showed an AUC of 0.627(95%CI:0.593-0.689,P<0.005),and the optimal cut point value for diagnosis was 0.69,at which the sensitivity and specificity were 42.57%and 96.03%,respectively.Conclusion:According to the independent influencing factors of IHCA in COPD patients complicated with respiratory failure,the establishment of a risk prediction nomogram model has high predictive value,which is worthy of clinical promotion.

GIDS在老年AECOPD呼吸衰竭患者病情及预后评估中的应用

目的 探讨胃肠道功能障碍评分(GIDS)与老年慢性阻塞性肺疾病急性加重期(AECOPD)呼吸衰竭患者疾病严重程度的相关性及对预后的预测价值,为疾病严重程度和预后评估提供参考依据。方法 收集2020年1月至2023年8月于该院ICU治疗的264例老年AECOPD呼吸衰竭患者作为研究对象。根据患者GIDS,将患者分为低GIDS组(0~1分)和高GIDS组(2~4分)。比较不同GIDS组患者急性生理与慢性健康状况评分系统Ⅱ(APACHEⅡ)评分和序贯器官衰竭评估(SOFA)评分,以及患者住院结局指标,包括机械通气时间、ICU入住时间和预后情况。采用Spearman相关分析GIDS与APACHEⅡ评分、SOFA评分的相关性。采用受试者工作特征(ROC)曲线分析GIDS对预后的预测价值。结果 264例老年AECOPD呼吸衰竭患者GIDS为2.00(1.00,3.00)分,其中0分53例(20.1%),1分65例(24.6%),2分53例(20.1%),3分45例(17.0%),4分48例(18.2%)。高GIDS组APACHEⅡ评分和SOFA评分高于低GIDS组(P<0.05)。Spearman相关性分析结果显示,GIDS与APACHEⅡ评分、SOFA评分均呈正相关(r=0.458、0.392,P<0.05)。高GIDS组机械通气时间、ICU入住时间长于低GIDS组,预后不良发生率高于低GIDS组,差异均有统计学意义(P<0.05)。ROC曲线结果显示,GIDS预测老年AECOPD呼吸衰竭患者预后不良的曲线下面积为0.823,灵敏度和特异度分别为93.4%和60.1%。结论 老年AECOPD呼吸衰竭患者GIDS与疾病严重程度密切相关,该评分对患者预后不良具有良好的预测价值。

肝细胞特异性对比剂增强磁共振动脉期呼吸运动伪影的影响因素

目的分析肝细胞特异性对比剂增强磁共振患者动脉期呼吸运动伪影的影响因素,为采取针对性护理干预降低伪影发生率提供参考。方法回顾性分析233例初次行肝细胞特异性对比剂增强磁共振检查住院患者的临床资料,采用单因素及logistic回归分析确定动脉期呼吸运动伪影的危险因素。结果30.90%患者发生动脉期呼吸运动伪影。回归分析显示,文化程度、身体质量指数、心力衰竭、慢性阻塞性肺疾病、腹水是肝细胞特异性对比剂增强磁共振动脉期呼吸运动伪影发生的危险因素(均P<0.05)。结论肝细胞特异性对比剂增强磁共振检查患者动脉期呼吸运动伪影发生率高,影响因素较多。对高风险患者应及时干预,以降低动脉期呼吸运动伪影发生率。

苏子降气汤结合机械通气治疗慢性阻塞性肺疾病伴呼吸衰竭临床研究

目的:观察苏子降气汤结合机械通气治疗慢性阻塞性肺疾病伴呼吸衰竭的临床疗效。方法:选择82例慢性阻塞性肺疾病伴呼吸衰竭患者作为研究对象,采用随机数字表法分为对照组和观察组各41例。在支持治疗的基础上,对照组给予机械通气治疗,观察组给予苏子降气汤结合机械通气治疗。评价2组临床疗效,比较2组治疗前后生命体征、肺功能指标及炎症因子水平。结果:观察组总有效率为97.56%,高于对照组85.37%(P<0.05)。治疗后,2组呼吸频率、心率较治疗前降低(P<0.05),且观察组体温、呼吸频率、心率低于对照组(P<0.05)。治疗后,2组第1秒用力呼气容积(FEV_(1))、用力肺活量(FVC)、FEV_(1)/FVC较治疗前升高(P<0.05),且观察组FEV_(1)、FVC、FEV_(1)/FVC高于对照组(P<0.05)。治疗后,2组降钙素原(PCT)、肿瘤坏死因子-α(TNF-α)、白细胞介素-4(IL-4)水平较治疗前降低(P<0.05),且观察组PCT、TNF-α、IL-4水平低于对照组(P<0.05)。结论:苏子降气汤结合机械通气治疗慢性阻塞性肺疾病伴呼吸衰竭患者,可提高临床疗效,改善患者生命体征,提高肺功能,缓解炎症反应。

无创机械通气联合呼吸训练在AECOPD合并呼吸衰竭患者中的应用评价

目的:探讨无创机械通气联合呼吸训练对慢性阻塞性肺疾病急性加重期(AECOPD)合并呼吸衰竭患者的效果。方法:前瞻性纳入2019年2月—2022年2月桂林医学院附属医院急诊科收治的AECOPD合并呼吸衰竭患者共67例,采用随机数字表法将患者分为两组。对照组(n=33)接受间断无创机械通气治疗,观察组(n=34)在对照组基础上增加主动呼吸训练(包括上肢弹力带阻抗训练、缩唇腹式呼吸、呼吸训练器使用)。记录两组2 d内撤机成功率、不良反应发生率,比较两组氧合指数(OI)、动脉血二氧化碳分压(PaCO_(2))、改良版英国医学研究委员会(mMRC)呼吸困难问卷分级、呼吸频率(RR)、自主呼吸潮气量。结果:对照组2 d内撤机成功率为60.6%,观察组为82.4%,观察组的撤机成功率高于对照组(P<0.05);观察组咳痰乏力、呼吸疲劳发生率均低于对照组(P<0.05);与治疗前相比,两组患者治疗2 d后的OI和PaCO_(2)均有显著改善,差异均有统计学意义(P<0.05);治疗2 d后,观察组PaCO_(2)低于对照组(P<0.05),但两组OI比较,差异无统计学意义(P>0.05);与治疗前相比,两组患者治疗2 d后的mMRC呼吸困难问卷分级和RR均有明显下降,自主呼吸潮气量均有明显提升,差异均有统计学意义(P<0.05);治疗2 d后,两组mMRC呼吸困难问卷分级和RR比较,差异均无统计学意义(P>0.05),但观察组患者自主呼吸潮气量明显高于对照组(P<0.05)。结论:AECOPD合并呼吸衰竭患者进行无创机械通气联合呼吸训练,能有效改善呼吸肌疲劳,增加肺通气,提高撤机成功率。

适应性支持通气对COPD并发呼吸衰竭患者肺损伤及撤机成功率的影响

目的:观察适应性支持通气对慢性阻塞性肺疾病(COPD)并发呼吸衰竭患者肺损伤及撤机成功率的影响。方法:选取南昌市洪都中医院2020年8月—2023年8月收治的80例行机械通气治疗的COPD并发呼吸衰竭患者为对象,按随机数字表法分为A组(适应性支持通气模式)、B组(同步间歇指令+压力支持通气模式),各40例。比较两组血气指标、呼吸功能、急性生理与慢性健康状况评价Ⅱ(APACHEⅡ)评分、不良事件及撤机情况。结果:治疗后,两组动脉氧分压(PaO_(2))、动脉二氧化碳分压(PaCO_(2))、酸碱度(pH值)、APACHEⅡ评分比较,差异均无统计学意义(P>0.05)。A组一次性撤机成功率、达峰时间比(TPTEF/TE)、达峰容积比(VPEF/VE)均高于B组,吸呼比(TI/TE)、呼吸频率(RR)均低于B组,差异均有统计学意义(P<0.05)。两组治疗期间不良事件发生率比较,差异无统计学意义(P>0.05)。结论:适应性支持通气用于COPD并发呼吸衰竭患者能更好地改善呼吸功能,提高一次性撤机成功率。

多学科协作模式在慢性阻塞性肺疾病合并呼吸衰竭患者中的作用

目的探讨多学科协作模式对慢性阻塞性肺疾病(COPD)合并呼吸衰竭患者预后与生活质量的影响。方法选取医院2021年6月—2022年6月收治的COPD合并呼吸衰竭患者94例为研究对象,按照组间基本资料均衡可比的原则分为对照组和观察组,每组47例。对照组给予常规治疗、常规护理与健康教育、肺康复指导,观察组采用多学科协作护理模式,首先组建多学科协作小组,小组人员共同查房,同时进行呼吸道管理、康复训练、营养干预、心理干预、健康教育及出院指导。比较两组患者干预前后肺功能指标、营养与免疫状况、情绪状况、治疗时间、生活质量及出院后3个月复发情况。结果干预后,观察组各项肺功能指标高于对照组(P<0.05);干预后观察组血清总蛋白、白蛋白、CD4^(+)、CD4^(+)/CD8^(+)高于对照组(P<0.05);干预后观察组焦虑、抑郁评分低于对照组(P<0.05);观察组呼吸功能恢复时间、ICU停留时间、住院时间短于对照组(P<0.05);观察组出院3个月急性加重次数低于对照组(P<0.05);干预后,观察组生活质量各项得分低于对照组(P<0.05)。结论针对COPD合并呼吸衰竭患者实施多学科协作模式,可促进呼吸功能恢复、改善营养与免疫状况,缓解不良情绪,改正不良的康复行为方式,缩短恢复时间及住院时间,防止病情复发,提高患者生活质量。

Analysis of risk factors for hospital mortality in patients with chronic obstructive pulmonary diseases requiring invasive mechanical ventilation

Background Accurate prediction for prognosis is important for hospitalized patients with chronic obstructive pulmonary disease （COPD） requiring invasive mechanic ventilation （IMV） and for their family members to make end-of-life decisions. The response to therapy in such a patient population has rarely been investigated. The aim of the study was to evaluate the risk factors in these patients and investigate their response to IMV and the relationship between their responses and prognosis. Methods A cohort of 138 patients with COPD requiring IMV≥12 hours for acute respiratory failure of diverse etiological factors during a 4-year period were retrospectively studied using prospectively gathered data. All variables potentially related to hospital mortality were evaluated by univariate and multiple stepwise logistic regression analysis. Results The mean age of all patients investigated was （65.7±11.6） years and the hospital mortality was 39.9% （31.1% with COPD exacerbation）. Correction of acidosis （pHi〉7.30） was seen in 58 patients （69.9%） in survivors but only 12 patients （21.8%） in nonsurvivors （P〈0.05） after ventilation. Using multivariate logistic analysis, the variables independently associated with hospital mortality were a higher acute physiology score before intubation, lower pH value measured 24 hours after the onset of ventilation and development of multiorgan dysfunction syndrome （MODS）. Conclusions In COPD patients requiring IMV, the postintubation pH value can not only reflect patients＇ response to treatment, but also serve as an independent determinant of hospital mortality apart from other risk factors such as a higher preintubation APACHE II score and development of MODS. A close correlation between the response to IMV and prognosis was proved in these patients.

基于三度空间模型的精细化护理在AECOPD并呼吸衰竭患者中的实践研究

目的探讨基于三度空间模型的精细化护理在慢性阻塞性肺疾病急性加重期(AECOPD)并呼吸衰竭患者中的应用效果。方法选取无锡市第二人民医院2020年8月至2022年3月收治的98例AECOPD并呼吸衰竭患者进行随机对照试验,利用随机数字表法分为观察组(49例)与对照组(49例)。对照组男性31例,女性18例,年龄51~79(64.56±8.15)岁,给予常规护理;观察组男性29例,女性20例,年龄53~80(66.23±7.36)岁,在对照组的基础上给予三度空间模型的精细化护理。比较两组患者护理前后自护能力、动脉血气指标、肺功能指标、生活质量以及并发症发生情况。统计学方法采用t检验、χ^(2)检验。结果护理后,两组患者自我护理技能、健康知识水平、自我概念、自护责任感评分均较护理前升高,且观察组均高于对照组[(40.92±10.23)分比(33.56±8.39)分、(49.83±12.21)分比(39.62±9.91)分、(32.96±8.24)分比(23.49±5.87)分、(28.76±7.19)分比(22.26±5.57)分],差异均有统计学意义(t=3.89、4.55、6.55、5.00,均P<0.05)。护理后,两组患者氧饱和度(SaO_(2))、动脉血氧分压(PaO_(2))、用力肺活量占正常预计值百分比(FVC%)、第一秒用力呼气量占正常预计值百分比(FEV_(1)%)、第一秒用力呼气量占用力肺活量百分率(FEV_(1)/FVC%)均较护理前升高,且观察组均高于对照组,二氧化碳分压(PaCO_(2))低于对照组[(96.86±24.22)%比(84.12±21.03)%、(88.79±22.19)mmHg(1 mmHg=0.133 kPa)比(73.21±18.30)mmHg、(2.63±0.66)%比(2.29±0.57)%、(1.46±0.37)%比(1.28±0.32)%、(0.67±0.17)%比(0.58±0.15)%、(46.58±11.65)mmHg比(58.67±4.67)mmHg],差异均有统计学意义(t=2.78、3.78、2.73、2.58、2.78、4.52,均P<0.05);护理后,两组患者疾病影响、症状评分、圣乔治呼吸问卷(SGRQ)总分均较护理前降低,且观察组均低于对照组,活动能力评分高于对照组[(20.74±4.15)分比(29.46±5.89)分、(37.86±7.57)分比(49.58±9.92)分、(29.56±7.39)分比(38.76±9.69)分、(62.85±12.57)分比(52.32±10.46)分],差异均有统计学意义(t=8.47、6.58、6.61、4.51,均P<0.05);观察组患者并发症总发生率低于对照组[6.12%(3/49)比24.49%(12/49)],差异有统计学意义(χ^(2)=5.04,P<0.05)。结论基于三度空间模型的精细化护理应用于AECOPD并呼吸衰竭患者,有利于改善患者的肺通气、换气功能,提高患者自护能力和生活质量,降低并发症发生率,值得临床推广。

危重症专职护理联合改良式体位管理在慢性阻塞性肺疾病呼吸衰竭机械通气患者中的应用

目的探讨危重症专职护理联合改良式体位管理在慢性阻塞性肺疾病呼吸衰竭(RF)机械通气(MV)患者中的应用效果。方法选取2021年1月至2023年1月九江市第一人民医院收治的61例慢性阻塞性肺疾病RF患者作为研究对象,按照随机数字表法分为对照组(30例)和观察组(31例)。对照组患者采用危重症专职护理,观察组患者采用危重症专职护理联合改良式体位管理。比较两组患者的心功能、血气指标、临床指标、并发症发生率和呼吸机相关性肺炎(VAP)发生率。结果两组患者护理前的左室射血分数(LVEF)、第1秒用力呼气容积(FEV1)、动脉血氧分压(PaO_(2))、动脉血二氧化碳分压(PaCO_(2))比较,差异无统计学意义(P>0.05)。两组护理后的LVEF、FEV1、PaO_(2)均高于本组护理前,PaCO_(2)均低于本组护理前,差异有统计学意义(P<0.05);观察组护理后的LVEF、FEV1、PaO_(2)均高于对照组,PaCO_(2)低于对照组,差异有统计学意义(P<0.05)。观察组的机械通气时间、ICU入住时间和住院时间均短于对照组,VAP发生率和并发症发生率均低于对照组,差异有统计学意义(P<0.05)。结论在行MV治疗的慢性阻塞性肺疾病RF患者中应用危重症专职护理联合改良式体位管理可改善心功能及血气指标,缩短机械通气、ICU入住及住院时间,降低并发症及VAP发生率,值得推广。

益气活血化痰汤治疗慢阻肺并呼吸衰竭临床观察

目的探讨益气活血化痰汤治疗慢性阻塞性肺疾病(简称慢阻肺)并呼吸衰竭的效果。方法选取2020年1月—2022年9月就诊于灌云县中医院中医内科的慢阻肺并呼吸衰竭患者64例。按治疗方法分入研究组与对照组,每组32例。对照组采取常规西药治疗方案,研究组在该方案基础上增加益气活血化痰汤。对2组中医证候积分、肺功能以及免疫功能指标予以比较。结果治疗后研究组主症与次症积分均低于对照组(P<0.05);研究组FVC、FEV_(1)以及FEV_(1)/FVC均大于对照组(P<0.05);研究组治疗后CD_(3)^(+)与CD_(4)^(+)以及CD_(4)^(+)/CD_8^(+)均高于对照组(P<0.05)。结论慢阻肺并呼吸衰竭治疗中增加益气活血化痰汤,可明显改善肺功能以及免疫功能,缓解症状与体征。